Stock-Encyclopedia.com

U.S.-Listed ETF listed on a U.S. stock exchange



The ETF: BioShares Biotechnology Products Fund (BBP)

 

Categories:

All ETFs  >  Stock ETFs  >  By Industry  >  Technology  >  Biotechnology
Advertisement        


BioShares Biotechnology Products Fund
The objective of the BioShares Biotechnology Products Fund is to invest in biotechnology companies with lead drugs already having received FDA approval. Products stage companies are typically more established companies with much clinical trial failure risk behind them. They have already successfully completed multiple human clinical trials and have received FDA approval to sell and market a drug. They devote more of their energies toward educating patients, physicians and insurance providers so as to drive sales and profit growth.

Investment type: ETF (Exchange-Traded Fund); listed on the U.S. NYSE exchange

Ticker symbol: BBP

Fund manager: BioShares

Fund information from BioShares: BioShares Biotechnology Products Fund

Fund launched:



ETF charts and further information:
NYSE

Delayed Quote
SEC Filings
Bloomberg

Delayed quote
Charting
Yahoo

RT quote
Charting
Headlines
Boards
Google

RT quote
Charting
Headlines
Discussion
MSN Money

RT quote
Charting
Options
Motley Fool

Delayed quote
Analysis
SEC Filings
Community
Seeking Alpha

Delayed quote
Analysis
StockCharts

Daily charts
 

 
 

 

Disclaimers:
• Information on this website should not be considered to be investment advice. Any ETF can go DOWN as well as up.
• Information on this website should not be assumed to be complete or correct. Funds can also change their investment goals. That's why, wherever possible, we provide links to the actual fund sponsor and the exchange on which the fund trades.

Created by Specifica, Inc.: Original content and unique compilation of information are copyright 2007-2015.